Clinical Trial Update: DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update indicates the study evaluating DX-8951f in children with advanced solid tumors or lymphomas has completed. The listed conditions i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors
• Central Nervous System Tumors
• Lymphoma
• Solid Tumors

Drugs mentioned

• DX-8951f

Snippet

Sponsor: Daiichi Sankyo | Conditions: Brain and Central Nervous System Tumors, Lymphoma | Phase 1 | Status: COMPLETED